GNPNAT1 and prostate carcinoma: Besides, the mRNA and protein levels of GNPNAT1 and UAP1, as well as the ratio of the intermediate metabolites (GlcNAc-6-P/GlcN-6-P), are significantly elevated in prostate cancers, compared with benign prostatic hyperplasia.